FCGR2B and in situ carcinoma: Serum BAFF levels in patients with CIS or MS negatively correlated with the expression of CD32b on naive B cells (p = 0.043; Figure 6A) and IgMlo MZ-like B cells (p = 0.02; Figure 6B), but not with other B cell subsets.